Source: http://usptopost-grant.com/35-usc-%C2%A7-257/
Timestamp: 2013-05-18 20:46:50
Document Index: 695856634

Matched Legal Cases: ['§ 257', '§ 102', '§ 103', '§ 112', '§ 119', '§ 122', '§ 135', '§ 257', '§ 273', '§ 291', '§ 311', '§ 312', '§ 313', '§ 314', '§ 315', '§ 316', '§ 318', '§ 319', '§ 321', '§ 322', '§ 323', '§ 324', '§ 325', '§ 326', '§ 327', '§ 328', '§ 329', '§ 312', '§ 122', '§ 301', '§ 257', '§ 257', '§ 12', '§ 12']

35 USC § 257 – Supplemental examination | USPTO Post-Grant Proceedings
Resources	Amended 35 USC35 USC § 102
35 USC § 103
35 USC § 112
35 USC § 119
35 USC § 122
35 USC § 135
35 USC § 257
35 USC § 273
35 USC § 291
35 USC § 311
35 USC § 312
35 USC § 313
35 USC § 314
35 USC § 315
35 USC § 316
35 USC § 318
35 USC § 319
35 USC § 321
35 USC § 322
35 USC § 323
35 USC § 324
35 USC § 325
35 USC § 326
35 USC § 327
35 USC § 328
35 USC § 329
America Invents Act	Pub. L. 112-29 (2011)
USPTO Final Rules
Definitions of Covered Business Method Patent and Technological Invention
Estoppel of ex parte reexamination by IPR or PGR
Inter partes reexamination standard – §§ 312 and 313
Inter Partes Review, Post-Grant Review, and Covered Business Method Patent Rules
Interference Standing Order
Patent Trial Practice Guide
Preissuance submissions – § 122(e)
Rules of Practice for Trials
Submission of information under 35 USC § 301
USPTO Proposed Rules
USPTO public comments
35 USC § 257 – Supplemental examination
§ 257. Supplemental examinations to consider, reconsider, or correct information
(b) REEXAMINATION ORDERED.—If the certificate issued under subsection (a) indicates that a substantial new question of patentability is raised by 1 or more items of information in the request, the Director shall order reexamination of the patent. The reexamination shall be conducted according to procedures established by chapter 30, except that the patent owner shall not have the right to file a statement pursuant to section 304. During the reexamination, the Director shall address each substantial new question of patentability identified during the supplemental examination, notwithstanding the limitations in chapter 30 relating to patents and printed publication or any other provision of such chapter. (c) EFFECT.—
(A) PRIOR ALLEGATIONS.—Paragraph (1) shall not apply to an allegation pled with particularity in a civil action, or set forth with particularity in a notice received by the patent owner under section 505(j)(2)(B)(iv)(II) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(2)(B)(iv)(II)), before the date of a supplemental examination request under subsection (a) to consider, reconsider, or correct information forming the basis for the allegation.
(B) PATENT ENFORCEMENT ACTIONS.—In an action brought under section 337(a) of the Tariff Act of 1930 (19 U.S.C. 1337(a)), or section 281 of this title, paragraph (1) shall not apply to any defense raised in the action that is based upon information that was considered, reconsidered, or corrected pursuant to a supplemental examination request under subsection (a), unless the supplemental examination, and any reexamination ordered pursuant to the request, are concluded before the date on which the action is brought.
Pub. L. No. 112-29, § 12(a), 125 Stat. 325-27 (Sept. 16, 2011)
The amendments made by this section shall take effect upon the expiration of the 1-year period beginning on the date of the enactment of this Act and shall apply to any patent issued before, on, or after that effective date.
Pub. L. No. 112-29, § 12(c), 125 Stat. 327 (Sept. 16, 2011)
Topics	Business method review
The New Duty of Disclosure in Post-Grant Oppositions
USPTO Opposition Trial Rules Adopt Interference Procedures
The Future of ANDA Litigation under the America Invents Act– Will the Balance Shift to Favor Generics?
New U.S. Opposition Proceedings Provide Strategic Avenues for Patent Challengers
Archives	Select Month November 2012 September 2012 August 2012 May 2012 April 2012 February 2012 January 2012 December 2011 November 2011 Useful Sites
e-CFR, 37 CFR
US patent litigation statistics
USPTO America Invents Act FAQ
USPTO Implementation Information
© 2013 Kenneth Burchfiel. All Rights Reserved. LEGAL DISCLAIMER.